10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q

(Mark One)
☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the period ended October 1, 2022
or

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from            to

Commission file number            0-16088

CPS TECHNOLOGIES CORP.

(Exact Name of Registrant as Specified in its Charter)

Delaware (State or Other Jurisdiction of Incorporation or Organization	04-2832509 (I.R.S. Employer Identification No.)
111 South Worcester Street Norton MA (Address of principal executive offices)	02766-2102 (Zip Code)

(508) 222-0614
Registrants Telephone Number, including Area Code:

CPS Technologies Corp.

111 South Worcester Street

Norton, MA 02766-2102

Former Name, Former Address and Former Fiscal Year if Changed since Last Report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period than the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15U.S.C. 7262(b)) by the registered firm that prepared or issued its audit report.

☐ Yes ☒ No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act):
☐ Yes ☒ No

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	CPSH	NASDAQ Capital Markets

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. Number of shares of common stock outstanding as of October 24, 2022: 14,438,786.

PART I FINANCIAL INFORMATION

ITEM 1 FINANCIAL STATEMENTS (Unaudited)

CPS TECHNOLOGIES CORP.
Balance Sheets (Unaudited)
(continued on next page)

	October 1,			December 25,
	2022			2021
ASSETS
Current assets:
Cash and cash equivalents	$	5,598,503		$	5,050,312
Accounts receivable-trade, net		5,835,738			4,870,021
Inventories, net		4,868,550			3,911,602
Prepaid expenses and other current assets		246,680			225,873
Total current assets		16,549,471			14,057,808
Property and equipment:
Production equipment		10,771,477			10,489,729
Furniture and office equipment		940,128			673,305
Leasehold improvements		968,509			951,384
Total cost		12,680,114			12,114,418
Accumulated depreciation and amortization		(11,317,632	)		(11,028,154	)
Construction in progress		46,267			246,669
Net property and equipment		1,408,749			1,332,933
Right-of-use lease asset		497,000			586,000
Deferred taxes, net		2,118,223			2,823,978
Total assets	$	20,573,443		$	18,800,719

See accompanying notes to financial statements.

CPS TECHNOLOGIES CORP.
Balance Sheets (Unaudited)
(concluded)

	October 1,			December 25,
	2022			2021
LIABILITIES AND STOCKHOLDERS` EQUITY
Current liabilities:
Note payable, current portion		43,136			55,906
Accounts payable		2,044,857			2,100,251
Accrued expenses		865,537			1,086,429
Deferred revenue		1,707,138			1,707,138
Lease liability, current portion		157,000			155,000
Total current liabilities		4,817,668			5,104,724
Note payable less current portion		65,947			98,684
Long term lease liability		340,000			431,000
Total liabilities		5,223,615			5,634,408
Commitments (note 4)
Stockholders` equity:
Common stock, $0.01 par value, authorized 20,000,000 shares; issued 14,438,786 and 14,350,786, respectively; outstanding 14,434,468 and 14,348,451, respectively; at October 1, 2022 and December 25, 2021;		144,388			143,508
Additional paid-in capital		39,620,372			39,281,810
Accumulated deficit		(24,394,083	)		(26,256,492	)
Less cost of 4,318 and 335 common shares repurchased, respectively; at October 1, 2022 and December 25, 2021		(20,849	)		(2,515	)
Total stockholders` equity		15,349,828			13,166,311
Total liabilities and stockholders` equity	$	20,573,443		$	18,800,719

See accompanying notes to financial statements.

CPS TECHNOLOGIES CORP.
Statements of Operations (Unaudited)

	Fiscal Quarters Ended						Nine Months Ended
	October 1,			September 25,			October 1,			September 25,
	2022			2021			2022			2021
Revenues:
Product sales	$	6,748,117		$	5,514,872		$	20,471,574		$	16,242,762
Total Revenues		6,748,117			5,514,872			20,471,574			16,242,762
Cost of product sales		4,864,876			4,375,676			14,796,206			12,807,844
Gross Margin		1,883,241			1,139,196			5,675,368			3,434,918
Selling, general and administrative expense		1,174,581			1,227,258			3,750,131			3,234,344
Operating income (loss)		708,660			(88,062	)		1,925,237			200,574
Interest income (expense), net		(1,892	)		(2,633	)		(6,245	)		(32,776	)
Other income (expense), net		645,594			18,665			649,628			30,728
Net income (loss) before income tax expense		1,352,362			(72,030	)		2,568,620			198,526
Income tax provision (benefit)		364,497			(2,799,997	)		706,211			(2,799,541	)
Net income	$	987,865		$	2,727,967		$	1,862,409		$	2,998,067
Net income per basic common share	$	0.07		$	0.19		$	0.13		$	0.21
Weighted average number of basic common shares outstanding		14,434,468			14,324,136			14,417,995			13,963,563
Net income per diluted common share	$	0.07		$	0.18		$	0.13		$	0.21
Weighted average number of diluted common shares outstanding		14,686,476			14,811,259			14,683,632			14,542,356

See accompanying notes to financial statements.

CPS TECHNOLOGIES CORP.
STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED October 1, 2022 AND SEPTEMBER 25, 2021

	Common Stock
	Number of				Additional									Total
	shares				paid-in			Accumulated			Stock			stockholders'
	issued		Par Value		capital			deficit			repurchased			equity
Balance at July 2, 2022		14,438,786	$	144,388	$	39,600,085			(25,381,948	)		(20,849	)		14,341,676
Share-based compensation expense		-		-		43,422			-			-			43,422
Issuance of common stock (net of costs)		-		-		(23,135	)		-			-			(23,135	)
Employee option exercises		-		-		-						-			-
Net income									987,865			-			987,865
Balance at October 1, 2022		14,438,786		144,388		39,620,372			(24,394,083	)		(20,849	)		15,349,828

	Common Stock
	Number of				Additional									Total
	shares				paid-in			Accumulated			Stock			stockholders'
	issued		Par Value		capital			deficit			repurchased			equity
Balance at December 25, 2021		14,350,786	$	143,508	$	39,281,810			(26,256,492	)		(2,515	)		13,166,311
Share-based compensation expense		-		-		207,277			-			-			207,277
Issuance of common stock (net of costs)		-		-		(40,893	)		-			-			(40,893	)
Employee options exercised		88,000		880		172,178						(18,334	)		154,724
Treasury shares		-		-		-			-			-			-
Net income									1,862,409			-			1,862,409
Balance at October 1, 2022		14,438,786		144,388		39,620,372			(24,394,083	)		(20,849	)		15,349,828

	Common Stock
	Number of				Additional								Total
	shares				paid-in		Accumulated			Stock			stockholders'
	issued		Par Value		capital		deficit			repurchased			equity
Balance at June 26, 2021		14,300,771	$	143,007	$	38,956,952		(29,202,268	)		(1,770	)		9,895,921
Share-based compensation expense		-		-		28,117		-			-			28,117
Issuance of common stock (net of costs)		47,515		475		284,503		-			-			284,978
Employee option exercises		500		5		740					(745	)		-
Net income								2,727,967			-			2,727,967
Balance at September 25, 2021		14,348,786		143,487		39,270,312		(26,474,301	)		(2,515	)		12,936,983

	Common Stock
	Number of						Additional									Total
	shares						paid-in			Accumulated			Stock			stockholders'
	issued			Par Value			capital			deficit			repurchased			equity
Balance at December 26, 2020		13,746,242		$	137,462		$	36,688,894			(29,472,368	)		(996,323	)		6,357,665
Share-based compensation expense		-			-			147,652			-			-			147,652
Issuance of common stock (net of costs)		526,804			5,268			3,417,102			-			-			3,422,370
Employee options exercised		630,400			6,304			1,235,370						(1,230,445	)		11,229
Treasury shares retired		(554,660	)		(5,547	)		(2,218,706	)		-			2,224,253			-
Net income											2,998,067			-			2,998,067
Balance at September 25, 2021		14,348,786			143,487			39,270,312			(26,474,301	)		(2,515	)		12,936,983

See accompanying notes to financial statements.

CPS TECHNOLOGIES CORP.
Statements of Cash Flows (Unaudited)

	Nine Month Periods Ended
	October 1,			September 25,
	2022			2021
Cash flows from operating activities:
Net income	$	1,862,409		$	2,998,067
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities
Depreciation and amortization		316,469			411,465
Share-based compensation		207,277			147,653
Deferred taxes		705,755			(2,790,809	)
Gain on sale of property and equipment		-			(2,047	)
Changes in:
Accounts receivable-trade		(965,717	)		(2,117,387	)
Inventories		(956,948	)		(63,757	)
Prepaid expenses		(20,807	)		(60,809	)
Accounts payable		(55,394	)		789,864
Deferred revenue		-			1,138,620
Accrued expenses		(220,891)			98,108
Net cash provided by (used in) operating activities		872,153			548,968
Cash flows from investing activities:
Purchases of property and equipment		(392,286	)		(298,760	)
Proceeds from sale of property and equipment		-			2,047
Net cash provided by (used in) investing activities		(392,286	)		(296,713	)
Cash flows from financing activities:
Net borrowings on line of credit		-			-
Proceeds from employee stock options		154,724			11,229
Proceeds from issuance of common stock		(40,893	)		3,422,370
Payments on note payable		(45,507	)		(43,320	)
Net cash provided by (used in) financing activities		68,324			3,390,279
Net increase (decrease) in cash and cash equivalents		548,191			3,642,534
Cash and cash equivalents at beginning of period		5,050,312			195,203
Cash and cash equivalents at end of period	$	5,598,503		$	3,837,737
Supplemental disclosures of cash flows information:
Cash paid for income taxes	$	456		$	456
Cash paid for interest		6,243			32,776
Supplemental disclosures of non-cash activity:
Net exercise of stock options		18,334			441,022

See accompanying notes to financial statements.

CPS TECHNOLOGIES CORP.
Notes to Financial Statements
(Unaudited)

(1)          Nature of Business

CPS Technologies Corp. (the “Company” or “CPS”) provides advanced material solutions to the electronics, power generation, automotive and other industries. The Company’s primary advanced material solution is metal-matrix composites (MMC’s) which are a combination of metal and ceramic.

CPS also assembles housings and packages for hybrid circuits. These housings and packages may include components made of metal-matrix composites or they may include components made of more traditional materials such as aluminum, copper-tungsten, etc.

Using its proprietary MMC technology, the Company also produces light-weight armor, particularly for extreme environments and heavy ballistic threat levels.

The Company sells into several end markets including the aerospace & defense markets, wireless communications infrastructure market, high-performance microprocessor market, motor controller market, and other microelectronic markets.

(2)         Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to quarterly reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally accepted accounting principles.

The accompanying financial statements are unaudited. In the opinion of management, the unaudited financial statements of CPS reflect all normal recurring adjustments which are necessary to present fairly the financial position and results of operations for such periods.

The Company’s balance sheet at December 25, 2021 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

For further information, refer to the financial statements and footnotes thereto included in the Registrant’s Annual Report on Form 10-K for the year ended December 25, 2021 and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.cpstechnologysolutions.com.

The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

(3)   Net Income (loss) Per Common and Common Equivalent Share

Basic net income (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing net income (loss) by the sum of the weighted average number of common shares plus additional common shares that would have been outstanding if potential dilutive common shares had been issued for granted stock options and stock purchase rights. Common stock equivalents are excluded from the diluted calculations when a net loss is incurred as they would be anti-dilutive.

 

The following table presents the calculation of both basic and diluted EPS:

	Three Months Ended				Nine Months Ended
	October 1,		September 25,		October 1,		September 25,
	2022		2021		2022		2021
Basic EPS Computation:
Numerator:
Net income	$	987,865	$	2,727,967	$	1,862,409	$	2,998,067
Denominator:
Weighted average Common shares Outstanding		14,434,468		14,324,136		14,417,995		13,963,563
Basic EPS	$	0.07	$	0.19	$	0.13	$	0.21
Diluted EPS Computation:
Numerator:
Net income	$	987,865	$	2,727,967	$	1,862,409	$	2,998,067
Denominator:
Weighted average Common shares Outstanding		14,434,468		14,324,136		14,417,995		13,963,563
Dilutive effect of stock options		252,008		487,124		265,637		578,793
Total Shares		14,686,476		14,811,259		14,683,632		14,542,356
Diluted EPS	$	0.07	$	0.18	$	0.13	$	0.21

(4)   Commitments & Contingencies

Commitments

Leases

The Company has one real estate lease expiring in February 2026. CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration. None of these equipment leases have been capitalized as the Company elected an accounting policy for short-term leases, which allows lessees to avoid recognizing right-of-use assets and liabilities for leases with terms of 12 months or fewer.

The real estate lease expiring in 2026 (the “Norton facility lease”) is included as a right-of-use lease asset and corresponding lease liability on the balance sheet. This asset and liability was recognized based on the present value of lease payments over the lease term using the Company’s incremental borrowing rate at commencement date. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Operating Leases

The Norton facility lease comprises approximately 38 thousand square feet. The lease is triple net lease wherein the Company is responsible for payment of all real estate taxes, operating costs and utilities. The Company also has an option to renew the lease starting in March 2026 through February 2032. Annual rental payments range from $152 thousand to $165 thousand through maturity.

 

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s capitalized operating leases as of October 1, 2022

(Dollars in Thousands)	October 1, 2022
Maturity of capitalized lease liabilities	Lease payments
2022		41
2023		162
2024		165
2025		165
2026		28
Total undiscounted operating lease payments	$	561
Less: Imputed interest		(64	)
Present value of operating lease liability	$	497
Balance Sheet Classification
Current lease liability	$	157
Long-term lease liability		340
Total operating lease liability	$	497
Other Information
Weighted-average remaining lease term for capitalized operating leases (in months)		41
Weighted-average discount rate for capitalized operating leases		6.6	%

Operating Lease Costs and Cash Flows

Operating lease cost and cash paid was $41 thousand during the third quarter of 2022 and $120 thousand for the nine months ended October 1, 2022. These costs are related to its long-term operating lease. All other short-term leases were immaterial.

Finance Leases

The company does not have any finance leases.

(5)   Share-Based Payments

The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.

During the quarter ended October 1, 2022 there were 25,000 stock options granted under the Plan. There were 5,000 stock options granted under the Plan during quarter ended September 25, 2021.

 

During the quarter ended October 1, 2022, no options were exercised. During the quarter ended October 1, 2022, 10,000 options were forfeited and none expired. During the quarter ended September 25, 2021, 500 options were exercised at a weighted average price of $1.49, 32,500 options were forfeited and none expired.

During the quarter ended October 1, 2022, the Company did not repurchase any shares for employees to facilitate their exercise of stock options. During the quarter ended September 25, 2021 the Company repurchased 112 shares for employees to facilitate their exercise of stock options.

There were also 983,100 shares outstanding at a weighted average price of $2.44 with a weighted average remaining term of 6.3 years as of October 1, 2022, and there were 518,800 shares exercisable at a weighted average price of $2.03 with a weighted average remaining term of 4.3 years as of October 1, 2022. The Plan, as amended, is authorized to issue 1,500,000 shares of common stock. As of October 1, 2022, there were 915,800 shares available for future grants.

During the three and nine months ended October 1, 2022 the Company recognized approximately $43 thousand and $207 thousand, respectively as share-based compensation expense related to share and option grants. These amounts are included as a component of selling, general and administrative expenses in the statement of operations.

During the three and nine months ended September 25, 2021 the Company recognized approximately $28 thousand and $148 thousand, respectively as share-based compensation expense related to share and option grants. These amounts are included as a component of selling, general and administrative expenses in the statement of operations.

(6)   Inventories

Inventories consist of the following:

	October 1,			December 25,
	2022			2021
Raw materials	$	2,427,477		$	2,080,778
Work in process		2,032,969			1,309,572
Finished goods		574,417			805,159
Total inventory		5,034,863			4,195,509
Reserve for obsolescence		(166,313	)		(283,907	)
Inventories, net	$	4,868,550		$	3,911,602

(7)   Accrued Expenses

Accrued expenses consist of the following:

	October 1,		December 25,
	2022		2021
Accrued legal and accounting	$	38,148	$	79,917
Accrued payroll		693,382		905,698
Accrued other		134,007		100,814
	$	865,537	$	1,086,429

(8)   Line of Credit

In September 2019, the Company entered into a revolving line of credit (LOC) with Massachusetts Business Development Corporation (BDC) in the amount of $2.5 million. The agreement includes a demand note allowing the Lender to call the loan at any time. The Company may terminate the agreement without a termination fee after 3 years. In May of 2020 this credit line was increased to $3.0 million. The LOC is secured by the accounts receivable and other assets of the Company and had an interest rate of LIBOR plus 650 basis points. In May of 2021 the interest rate was reduced to LIBOR plus 550 basis points. On October 1, 2022, the Company had $0 of borrowings under this LOC and its borrowing base at the time would have permitted an additional $3.0 million to have been borrowed.

The line of credit is subject to certain financial covenants, all of which have been met or waived.

(9)   Note Payable         

In March 2020, the company acquired inspection equipment for a price of $208 thousand. The full amount was financed through a 5 year note payable with a third party equipment finance company. The note is collateralized by the equipment and is being paid in monthly installments of $4 thousand, consisting of principal plus interest at a rate of 6.47%.

In July 2020 CPS placed into service a piece of manufacturing equipment which it financed with the machine’s vendor. The equipment cost of $40 thousand was paid in full during the quarter ended October 1, 2022.

The aggregate maturities of the notes payable based on the payment terms of the agreement are as follows: 

Remaining in:	Payments due by period
FY 2022	$	10,399
FY 2023	$	43,837
FY 2024	$	46,757
FY 2025	$	8,090
Total		109,083

Total interest expense on notes payable during 2022 was $6,243.

(10)   Income Taxes

A valuation allowance against deferred tax assets is required to be established or maintained when it is "more likely than not" that all or a portion of deferred tax assets will not be realized. In December 2018, the Company established a valuation allowance reserve, as it is judged more likely than not that all or a portion of its deferred tax assets will not be utilized before they expire. This decision was reached after giving greater weight to the Company’s losses in recent years as compared to its forecasts.

In September 2021, this decision was reevaluated in light of the Company’s recent profitability and its forecasts for future profitability. The Company concluded that it is “more likely than not” that the Company will be able to fully utilize the deferred tax asset. This reversal of the valuation allowance was made net of the expected tax liability for 2021 in the amount of $2,790,201. For the third quarter of 2022 a charge against the tax asset of $364,497 for the estimated tax liability on Q3 income was made. For the 9 months ended October 1, 2022, a charge against the tax asset of $705,755 was made for the estimated tax liability on year-to-date income.  The Company has calculated its tax liability using a 21% rate for federal taxes and an 8.6% rate for state taxes.

(11)   Other Taxes

In Q3 the Company determined that it was eligible for the Employee Retention Tax Credit (“ERTC”). This amount was determined to be $641,086 and is included in Accounts Receivable and Other Income. The Company has filed its tax returns to reflect this income and has included its impact in the Q3 tax calculation.

ITEM 2        MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of financial condition and results of operations is based upon and should be read in conjunction with the financial statements of the Company and notes thereto included in this report and the Company’s Annual Report on Form 10-K for the year ended December 25, 2021.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that involve a number of risks and uncertainties. There are a number of factors that could cause the Company’s actual results to differ materially from those forecasted or projected in such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements which may be made to reflect events or changed circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Critical Accounting Policies

The critical accounting policies utilized by the Company in preparation of the accompanying financial statements are set forth in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 25, 2021, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. There have been no material changes to these policies since December 25, 2021.

Overview

Products we provide include baseplates for motor controllers used in high-speed electric trains, subway cars, wind turbines, and hybrid and electric vehicles. We provide baseplates and housings used in radar, satellite and avionics applications. We provide lids and heat spreaders used with high performance integrated circuits for use in internet switches and routers. We provide baseplates and housings used in modules built with Wide Band Gap Semiconductors like Silicon Carbide (“SiC”) and Gallium Nitride (“GaN”), collectively Metal Matrix Composites (“MMC”). CPS also assembles housings and packages for hybrid circuits. These housings and packages may include MMC components; they may include components made of more traditional materials such as aluminum, cold rolled steel and Kovar. Using its proprietary MMC technology, the Company also produces lightweight armor, particularly for extreme environments and heavy threat levels. 

CPS’s products are custom rather than catalog items. They are made to customers’ designs and are used as components in systems built and sold by our customers. At any point in time our product mix will consist of some products with on-going production demand, and some products which are in the prototyping or evaluation stages at our customers. The Company seeks to have a portfolio of products which include products in every stage of the technology adoption lifecycle at our customers. CPS’ growth is dependent upon the level of demand for those products already in production, as well as its success in achieving new "design wins" for future products.

As a manufacturer of highly technical and custom products, the Company incurs fixed costs needed to support the business, but which do not vary significantly with changes in sales volume. These costs include the fixed costs of applications such as engineering, tooling design and fabrication, process engineering, and others. Accordingly, particularly given our current size, changes in sales volume generally result in even greater changes in financial performance on a percentage basis as fixed costs are spread over a larger or smaller base. Sales volume is therefore a key financial metric used by management.

The Company believes the underlying demand for MMC, housings for hybrid circuits and our proprietary armor solution is growing as the electronics and other industries seek higher performance, higher reliability, and reduced costs. CPS believes that the Company is well positioned to offer our solutions to current and new customers as these demands grow. 

CPS was incorporated in Massachusetts in 1984 as Ceramics Process Systems Corporation and reincorporated in Delaware in April 1987 through a merger into a wholly-owned Delaware subsidiary organized for purposes of the reincorporation. In July 1987, CPS completed our initial public offering of 1.5 million shares of our Common Stock. In March 2007, we changed our name from Ceramics Process Systems Corporation to CPS Technologies Corp.

Results of Operations for the Third Fiscal Quarter of 2022 (Q3 2022) Compared to the Third Fiscal Quarter of 2021 (Q3 2021); (all $ in 000s)

Total revenue was $6,748 in Q3 2022, a 22% increase compared with total revenue of $5,515 in Q3 2021. This increase was due primarily to increases in the Company’s armor production as well as increases in sales to other customers in the aerospace and defense markets.

Gross margin in Q3 2022 totaled $1,883 or 28% of sales. In Q3 2021, gross margin was $1,139 or 21% of sales. This increase in margin directly correlates to the increased revenue and the impact increased revenue has on fixed manufacturing costs.

Selling, general and administrative expenses (SG&A) were $1,175 in Q3 2022, down 4% when compared with SG&A expenses of $1,227 in Q3 2021. This decrease was primarily due to non-recurring restructuring costs of $327 incurred in 2021, partially offset by an increase in variable compensation in 2022 incurred as a result of the Company’s increased revenue.

In Q3, 2022, the Company incurred interest expense of $2 due to equipment financing. This compares with interest expense of $3 in Q3 of 2021.

The Company generated operating income of $709 compared with an operating loss of $88 in the same quarter last year. This increase in operating income is due to the non-recurring restructuring costs, discussed above, as well as the impact of higher revenue on the absorption of fixed costs. The net income for Q3 2022 totaled $988 versus net income of $2,728 in Q3 2021. This differential in net income is due to the reversal of the deferred tax asset valuation allowance in Q3 2021, discussed in footnote 10 above, partially offset by the ERTC in 2022, discussed in footnote 11 above.  The pre-tax net in 2021 loss was $72.

Results of Operations for the First Nine Months of 2022 Compared to the First Nine Months of 2021 (all $ in 000s)

Total revenue was $20,472 in the first nine months of 2022, a 26% increase compared with total revenue of $16,243 in the first nine months of 2021. This increase was due to the growth of our armor and hermetic package product lines.

Gross margin in the first nine months of 2022 totaled $5,675 or 28% of sales. In the first nine months of 2021 gross margin totaled $3,435 or 21% of sales. This increase was due to higher sales volumes and the impact those higher volumes have on our fixed costs.

Selling, general and administrative (SG&A) expenses were $3,750 during the first nine months of 2022, up 16% compared with SG&A expenses of $3,234 in the first nine months of 2021. The hiring of our new CDO, increased variable compensation accruals due to higher 2022 operating profitability and increased costs associated commissions on armor product shipments were the primary reasons for this increase. 

During the first nine months of 2022, the Company incurred interest expense of $6 on its notes payable. This compares with interest expense of $33 incurred during the first nine months of 2021 which included the notes payable as well as bank borrowings in Q1 and Q2 of 2021.

In the first nine months of 2022 the Company generated operating income of $1,925 compared with operating income of $201 in the same period last year. Similar to revenue, the difference between the first quarter of 2022 compared to the Covid impacted first quarter of 2021, plus the non-recurring restructuring costs account for this difference. The net income for the first nine months of 2022 totaled $1,862 versus net income of $2,998 in the first nine months of 2021. This difference is due to the tax impact on Q3 2021 described in note 10 above offset by the ERTC in 2022 described in note 11 above.

Liquidity and Capital Resources (all $ in 000s unless noted)

The Company’s cash and cash equivalents at October 1, 2022 totaled $5,599. This compares to cash and cash equivalents at December 25, 2021 of $5,050. The increase in cash was primarily due to our net profit, offset by increased accounts receivable and inventory to support higher sales.

Accounts receivable at October 1, 2022 totaled $5,836 compared with $4,870 at December 25, 2021. The Q3 2022 total includes $641 receivable for the ERTC.

Days Sales Outstanding (DSO) decreased from 72 days at the end of 2021 to 69 days at the end of Q3 2022, based on trade receivables. This decrease was due to deferred revenue included in accounts receivable at the end of 2021 not yet reflected in revenue. The accounts receivable balances at December 25, 2021, and October 1, 202 were both net of an allowance for doubtful accounts of $10.

Inventories totaled $4,869 at October 1, 2022 compared with inventory totaling $3,912 at December 25, 2021. The increase in inventory was necessary to support rising sales and due to product mix, as some products are more labor intensive, while others are more materials intensive. The inventory turnover in the most recent four quarters ending Q3 2022 was 4.5 times, slightly down from 4.6 times averaged during the four quarters of 2021 (based on a 5 point average).

The Company financed its working capital during the first nine months of 2022 from its net profit during the period. The Company expects it will continue to be able to fund its working capital requirements for the remainder of 2022 from existing cash balances.

Although the Company’s customer base is expanding, the Company continues to sell to a limited number of customers and the loss of any one of these customers could cause the Company to require additional external financing. Failure to generate sufficient revenues, raise additional capital or reduce certain discretionary spending could have a material adverse effect on the Company’s ability to achieve its business objectives.

Contractual Obligations

In September 2019, the Company entered into revolving line of credit (LOC) with Massachusetts Business Development Corporation (BDC) in the amount of $2.5 million. This agreement was amended in May 2020 to increase the line to $3.0 million. The agreement includes a demand note allowing the Lender to call the loan at any time. The Company may terminate the agreement without a termination fee after 3 years. The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of LIBOR plus 550 basis points. The Company was in compliance with all debt covenants as of October 1, 2022, had $0 borrowings under this LOC and its borrowing base at the time would have permitted $3.0 million to have been borrowed.

In March 2020, the company acquired a scanning acoustic microscope for a price of $208 thousand. The full amount was financed through a 5 year note payable with a financing company. The note is collateralized by the microscope and is being paid in monthly installments of $4 thousand, consisting of principal plus interest at a rate of 6.47%.

In July 2020 CPS placed into service a piece of manufacturing equipment which it financed through a capital lease with the machine’s vendor. The original lease amount was $40 thousand and will be paid at the rate of $2 thousand per month over 2 years with an interest rate of 1.9%.

As of October 1, 2022, the Company had $46 of construction in progress and no outstanding commitments to purchase production equipment.

The Company has one real estate lease expiring in February 2026. CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration. None of these have been capitalized. (Note 4, Leases)

Management believes that a combination of existing cash balances and borrowings, if necessary, will be sufficient to fund our cash requirements for the foreseeable future. However, there is no assurance that we will be able to generate sufficient revenues or reduce certain discretionary spending in the event that planned operational goals are not met such that we will be able to meet our obligations as they become due.

ITEM 3                  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is not significantly exposed to the impact of interest rate changes or foreign currency fluctuations. The Company has not used derivative financial instruments.

ITEM 4                  CONTROLS AND PROCEDURES

(a)         The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-14(c) and 15d - 14(c) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Form 10-Q (the “Evaluation Date”). Based on such evaluation, such officers have concluded that, as of the Evaluation Date, 1) the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports the Company files under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and 2) the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, to allow timely decisions regarding required disclosure.

(b)         Changes in Internal Controls. There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

PART II OTHER INFORMATION

ITEM 1                  LEGAL PROCEEDINGS
             None.

ITEM 1A               RISK FACTORS
             There have been no material changes to the risk factors as discussed in our 2020 Form 10-K

ITEM 2                  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
             None.

ITEM 3                  DEFAULTS UPON SENIOR SECURITIES
             None.

ITEM 4                  MINE SAFETY DISCLOSURES
             Not applicable.

ITEM 5                  OTHER INFORMATION
             Not applicable.

ITEM 6                  EXHIBITS
(a)         Exhibits:

Exhibit 31.1 Certification of Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 302 of The Sarbanes-Oxley Act Of 2002

Exhibit 31.2 Certification of Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 302 of The Sarbanes-Oxley Act Of 2002

Exhibit 32.1 Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act of 2002

101.INS Inline XBRL Instance Document

101.SCH Inline XBRL Taxonomy Extension Schema Document

101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

(b)          Reports on Form 8-K

None

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CPS TECHNOLOGIES CORP.
(Registrant)

Date: November 8, 2022

/s/ Michael E. McCormack

Michael E. McCormack
Chief Executive Officer

Date: November 8, 2022

/s/ Charles K. Griffith Jr.

Charles K. Griffith Jr.

Chief Financial Officer

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael E. McCormack, certify that:

I have reviewed this quarterly report on Form 10-Q;

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

The registrant`s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant`s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this quarterly report based on such evaluation (the "Evaluation Date"); and

d) Disclosed in this quarterly report any change in the registrant`s internal control over financial reporting that occurred during the registrant`s most recent fiscal quarter that has materially affected or is reasonably like to materially affect, the registrant`s internal control over financial reporting.

The registrant`s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant`s auditors and the audit committee of the registrant`s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant`s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant`s internal control over financial reporting.

Date: November 8, 2022
/s/ Michael E. McCormack
Michael E. McCormack
President and Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Charles K. Griffith Jr., certify that:

I have reviewed this quarterly report on Form 10-Q;

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

The registrant`s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant`s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this quarterly report based on such evaluation (the "Evaluation Date"); and

d) Disclosed in this quarterly report any change in the registrant`s internal control over financial reporting that occurred during the registrant`s most recent fiscal quarter that has materially affected or is reasonably like to materially affect, the registrant`s internal control over financial reporting.

The registrant`s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant`s auditors and the audit committee of the registrant`s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant`s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant`s internal control over financial reporting.

Date: November 8, 2022
/s/ Charles K. Griffith Jr.
Charles K. Griffith Jr.
Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of CPS Technologies Corporation (the "Company") on Form 10-Q for the nine month period ended October 1, 2022 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael E. McCormack, President and Chief Executive Officer of the Company, and I, Charles K. Griffith Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 8, 2022
/s/ Michael E. McCormack
Michael E. McCormack
President and Chief Executive Officer

Date: November 8, 2022
/s/ Charles K. Griffith Jr.
Charles K. Griffith Jr.
Chief Financial Officer

XML

Document And Entity Information - shares	9 Months Ended
	Oct. 01, 2022	Oct. 24, 2022
Document Information [Line Items]
Entity Central Index Key	0000814676
Entity Registrant Name	CPS TECHNOLOGIES CORP/DE/
Amendment Flag	false
Current Fiscal Year End Date	--12-25
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 01, 2022
Document Transition Report	false
Entity File Number	0-16088
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	04-2832509
Entity Address, Address Line One	111 South Worcester Street
Entity Address, City or Town	Norton
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02766-2102
City Area Code	508
Local Phone Number	222-0614
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	CPSH
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		14,438,786

XML

Balance Sheets (Current Period Unaudited) - USD ($)	Oct. 01, 2022	Dec. 25, 2021
Current assets:
Cash and cash equivalents	$ 5,598,503	$ 5,050,312
Accounts receivable-trade, net	5,835,738	4,870,021
Inventories, net	4,868,550	3,911,602
Prepaid expenses and other current assets	246,680	225,873
Total current assets	16,549,471	14,057,808
Property and equipment:
Production equipment	10,771,477	10,489,729
Furniture and office equipment	940,128	673,305
Leasehold improvements	968,509	951,384
Total cost	12,680,114	12,114,418
Accumulated depreciation and amortization	(11,317,632)	(11,028,154)
Construction in progress	46,267	246,669
Net property and equipment	1,408,749	1,332,933
Right-of-use lease asset	497,000	586,000
Deferred taxes, net	2,118,223	2,823,978
Total assets	20,573,443	18,800,719
Current liabilities:
Note payable, current portion	43,136	55,906
Accounts payable	2,044,857	2,100,251
Accrued expenses	865,537	1,086,429
Deferred revenue	1,707,138	1,707,138
Current lease liability	157,000	155,000
Total current liabilities	4,817,668	5,104,724
Note payable less current portion	65,947	98,684
Long-term lease liability	340,000	431,000
Total liabilities	5,223,615	5,634,408
Commitments (note 4)
Stockholders` equity:
Common stock, $0.01 par value, authorized 20,000,000 shares; issued 14,438,786 and 14,350,786, respectively; outstanding 14,434,468 and 14,348,451, respectively; at October 1, 2022 and December 25, 2021;	144,388	143,508
Additional paid-in capital	39,620,372	39,281,810
Accumulated deficit	(24,394,083)	(26,256,492)
Less cost of 4,318 and 335 common shares repurchased, respectively; at October 1, 2022 and December 25, 2021	(20,849)	(2,515)
Total stockholders` equity	15,349,828	13,166,311
Total liabilities and stockholders` equity	$ 20,573,443	$ 18,800,719

XML

Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Oct. 01, 2022	Dec. 25, 2021
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized shares (in shares)	20,000,000	20,000,000
Common stock, issued shares (in shares)	14,438,786	14,350,786
Common stock, outstanding shares (in shares)	14,434,468	14,348,451
Treasury stock, shares (in shares)	4,318	335

XML

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Sep. 25, 2021	Oct. 01, 2022	Sep. 25, 2021
Product sales	$ 6,748,117	$ 5,514,872	$ 20,471,574	$ 16,242,762
Total Revenues	6,748,117	5,514,872	20,471,574	16,242,762
Cost of product sales	4,864,876	4,375,676	14,796,206	12,807,844
Gross Margin	1,883,241	1,139,196	5,675,368	3,434,918
Selling, general and administrative expense	1,174,581	1,227,258	3,750,131	3,234,344
Operating income (loss)	708,660	(88,062)	1,925,237	200,574
Interest income (expense), net	(1,892)	(2,633)	(6,245)	(32,776)
Other income (expense), net	645,594	18,665	649,628	30,728
Net income (loss) before income tax expense	1,352,362	(72,030)	2,568,620	198,526
Income tax provision (benefit)	364,497	(2,799,997)	706,211	(2,799,541)
Net income	$ 987,865	$ 2,727,967	$ 1,862,409	$ 2,998,067
Net income per basic common share (in dollars per share)	$ 0.07	$ 0.19	$ 0.13	$ 0.21
Weighted average Common shares Outstanding (in shares)	14,434,468	14,324,136	14,417,995	13,963,563
Net income per diluted common share (in dollars per share)	$ 0.07	$ 0.18	$ 0.13	$ 0.21
Weighted average number of diluted common shares outstanding (in shares)	14,686,476	14,811,259	14,683,632	14,542,356

XML

Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Total
Balance (in shares) at Dec. 26, 2020	13,746,242
Balance at Dec. 26, 2020	$ 137,462	$ 36,688,894	$ (29,472,368)	$ (996,323)	$ 6,357,665
Share-based compensation expense		147,652			147,652
Issuance of common stock (net of costs)	$ (5,268)	(3,417,102)			(3,422,370)
Employee option exercises (in shares)	630,400
Employee option exercises	$ 6,304	1,235,370		(1,230,445)	11,229
Net income			2,998,067		2,998,067
Treasury shares (in shares)	(554,660)
Treasury shares	$ (5,547)	(2,218,706)		2,224,253
Issuance of common stock (net of costs) (in shares)	526,804
Issuance of common stock (net of costs)	$ 5,268	3,417,102			3,422,370
Balance (in shares) at Sep. 25, 2021	14,348,786
Balance at Sep. 25, 2021	$ 143,487	39,270,312	(26,474,301)	(2,515)	12,936,983
Balance (in shares) at Jun. 26, 2021	14,300,771
Balance at Jun. 26, 2021	$ 143,007	38,956,952	(29,202,268)	(1,770)	9,895,921
Share-based compensation expense		28,117			28,117
Issuance of common stock (net of costs)	$ (475)	(284,503)			$ (284,978)
Employee option exercises (in shares)	500				500
Employee option exercises	$ 5	740		(745)	$ 0
Net income			2,727,967		2,727,967
Issuance of common stock (net of costs) (in shares)	47,515
Issuance of common stock (net of costs)	$ 475	284,503			284,978
Balance (in shares) at Sep. 25, 2021	14,348,786
Balance at Sep. 25, 2021	$ 143,487	39,270,312	(26,474,301)	(2,515)	12,936,983
Balance (in shares) at Dec. 25, 2021	14,350,786
Balance at Dec. 25, 2021	$ 143,508	39,281,810	(26,256,492)	(2,515)	13,166,311
Share-based compensation expense		207,277			207,277
Issuance of common stock (net of costs)		(40,893)			(40,893)
Employee option exercises (in shares)	88,000
Employee option exercises	$ 880	172,178		(18,334)	154,724
Net income			1,862,409		1,862,409
Treasury shares (in shares)	0
Treasury shares	$ 0	0	0	0	0
Issuance of common stock (net of costs)		40,893			40,893
Balance (in shares) at Oct. 01, 2022	14,438,786
Balance at Oct. 01, 2022	$ 144,388	39,620,372	(24,394,083)	(20,849)	15,349,828
Balance (in shares) at Jul. 02, 2022	14,438,786
Balance at Jul. 02, 2022	$ 144,388	39,600,085	(25,381,948)	(20,849)	14,341,676
Share-based compensation expense		43,422			43,422
Issuance of common stock (net of costs)		(23,135)			$ (23,135)
Employee option exercises (in shares)	0				0
Employee option exercises	$ 0	0		0	$ 0
Net income			987,865		987,865
Issuance of common stock (net of costs)		23,135			23,135
Balance (in shares) at Oct. 01, 2022	14,438,786
Balance at Oct. 01, 2022	$ 144,388	$ 39,620,372	$ (24,394,083)	$ (20,849)	$ 15,349,828

XML

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Oct. 01, 2022	Sep. 25, 2021
Cash flows from operating activities:
Net income	$ 1,862,409	$ 2,998,067
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities
Depreciation and amortization	316,469	411,465
Share-based compensation	207,277	147,653
Deferred taxes	705,755	(2,790,809)
Gain on sale of property and equipment	0	(2,047)
Changes in:
Accounts receivable-trade	(965,717)	(2,117,387)
Inventories	(956,948)	(63,757)
Prepaid expenses	(20,807)	(60,809)
Accounts payable	(55,394)	789,864
Deferred revenue	0	1,138,620
Accrued expenses	(220,891)	98,108
Net cash provided by (used in) operating activities	872,153	548,968
Cash flows from investing activities:
Purchases of property and equipment	(392,286)	(298,760)
Proceeds from sale of property and equipment	0	2,047
Net cash provided by (used in) investing activities	(392,286)	(296,713)
Cash flows from financing activities:
Net borrowings on line of credit	0	0
Proceeds from employee stock options	154,724	11,229
Proceeds from issuance of common stock	(40,893)	3,422,370
Payments on note payable	(45,507)	(43,320)
Net cash provided by (used in) financing activities	68,324	3,390,279
Net increase (decrease) in cash and cash equivalents	548,191	3,642,534
Cash and cash equivalents at beginning of period	5,050,312	195,203
Cash and cash equivalents at end of period	5,598,503	3,837,737
Supplemental disclosures of cash flows information:
Cash paid for income taxes	456	456
Cash paid for interest	6,243	32,776
Supplemental disclosures of non-cash activity:
Net exercise of stock options	$ 18,334	$ 441,022

XML

Note 1 - Nature of Business

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Business Description and Basis of Presentation [Text Block]

(1)          Nature of Business

CPS Technologies Corp. (the “Company” or “CPS”) provides advanced material solutions to the electronics, power generation, automotive and other industries. The Company’s primary advanced material solution is metal-matrix composites (MMC’s) which are a combination of metal and ceramic.

CPS also assembles housings and packages for hybrid circuits. These housings and packages may include components made of metal-matrix composites or they may include components made of more traditional materials such as aluminum, copper-tungsten, etc.

Using its proprietary MMC technology, the Company also produces light-weight armor, particularly for extreme environments and heavy ballistic threat levels.

The Company sells into several end markets including the aerospace & defense markets, wireless communications infrastructure market, high-performance microprocessor market, motor controller market, and other microelectronic markets.

XML

Note 2 - Summary of Significant Accounting Policies

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Significant Accounting Policies [Text Block]

(2)         Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to quarterly reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally accepted accounting principles.

The accompanying financial statements are unaudited. In the opinion of management, the unaudited financial statements of CPS reflect all normal recurring adjustments which are necessary to present fairly the financial position and results of operations for such periods.

The Company’s balance sheet at December 25, 2021 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

For further information, refer to the financial statements and footnotes thereto included in the Registrant’s Annual Report on Form 10-K for the year ended December 25, 2021 and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.cpstechnologysolutions.com.

The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

XML

Note 3 - Net Income (Loss) Per Common and Common Equivalent Share

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Earnings Per Share [Text Block]

(3)   Net Income (loss) Per Common and Common Equivalent Share

Basic net income (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing net income (loss) by the sum of the weighted average number of common shares plus additional common shares that would have been outstanding if potential dilutive common shares had been issued for granted stock options and stock purchase rights. Common stock equivalents are excluded from the diluted calculations when a net loss is incurred as they would be anti-dilutive.

The following table presents the calculation of both basic and diluted EPS:

	Three Months Ended				Nine Months Ended
	October 1,		September 25,		October 1,		September 25,
	2022		2021		2022		2021
Basic EPS Computation:
Numerator:
Net income	$	987,865	$	2,727,967	$	1,862,409	$	2,998,067
Denominator:
Weighted average Common shares Outstanding		14,434,468		14,324,136		14,417,995		13,963,563
Basic EPS	$	0.07	$	0.19	$	0.13	$	0.21
Diluted EPS Computation:
Numerator:
Net income	$	987,865	$	2,727,967	$	1,862,409	$	2,998,067
Denominator:
Weighted average Common shares Outstanding		14,434,468		14,324,136		14,417,995		13,963,563
Dilutive effect of stock options		252,008		487,124		265,637		578,793
Total Shares		14,686,476		14,811,259		14,683,632		14,542,356
Diluted EPS	$	0.07	$	0.18	$	0.13	$	0.21

XML

Note 4 - Commitments & Contingencies

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

(4)   Commitments & Contingencies

Commitments

Leases

The Company has one real estate lease expiring in February 2026. CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration. None of these equipment leases have been capitalized as the Company elected an accounting policy for short-term leases, which allows lessees to avoid recognizing right-of-use assets and liabilities for leases with terms of 12 months or fewer.

The real estate lease expiring in 2026 (the “Norton facility lease”) is included as a right-of-use lease asset and corresponding lease liability on the balance sheet. This asset and liability was recognized based on the present value of lease payments over the lease term using the Company’s incremental borrowing rate at commencement date. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Operating Leases

The Norton facility lease comprises approximately 38 thousand square feet. The lease is triple net lease wherein the Company is responsible for payment of all real estate taxes, operating costs and utilities. The Company also has an option to renew the lease starting in March 2026 through February 2032. Annual rental payments range from $152 thousand to $165 thousand through maturity.

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s capitalized operating leases as of October 1, 2022

(Dollars in Thousands)	October 1, 2022
Maturity of capitalized lease liabilities	Lease payments
2022		41
2023		162
2024		165
2025		165
2026		28
Total undiscounted operating lease payments	$	561
Less: Imputed interest		(64	)
Present value of operating lease liability	$	497
Balance Sheet Classification
Current lease liability	$	157
Long-term lease liability		340
Total operating lease liability	$	497
Other Information
Weighted-average remaining lease term for capitalized operating leases (in months)		41
Weighted-average discount rate for capitalized operating leases		6.6	%

Operating Lease Costs and Cash Flows

Operating lease cost and cash paid was $41 thousand during the third quarter of 2022 and $120 thousand for the nine months ended October 1, 2022. These costs are related to its long-term operating lease. All other short-term leases were immaterial.

Finance Leases

The company does not have any finance leases.

XML

Note 5 - Share-based Payments

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

(5)   Share-Based Payments

The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.

During the quarter ended October 1, 2022 there were 25,000 stock options granted under the Plan. There were 5,000 stock options granted under the Plan during quarter ended September 25, 2021.

During the quarter ended October 1, 2022, no options were exercised. During the quarter ended October 1, 2022, 10,000 options were forfeited and none expired. During the quarter ended September 25, 2021, 500 options were exercised at a weighted average price of $1.49, 32,500 options were forfeited and none expired.

During the quarter ended October 1, 2022, the Company did not repurchase any shares for employees to facilitate their exercise of stock options. During the quarter ended September 25, 2021 the Company repurchased 112 shares for employees to facilitate their exercise of stock options.

There were also 983,100 shares outstanding at a weighted average price of $2.44 with a weighted average remaining term of 6.3 years as of October 1, 2022, and there were 518,800 shares exercisable at a weighted average price of $2.03 with a weighted average remaining term of 4.3 years as of October 1, 2022. The Plan, as amended, is authorized to issue 1,500,000 shares of common stock. As of October 1, 2022, there were 915,800 shares available for future grants.

During the three and nine months ended October 1, 2022 the Company recognized approximately $43 thousand and $207 thousand, respectively as share-based compensation expense related to share and option grants. These amounts are included as a component of selling, general and administrative expenses in the statement of operations.

During the three and nine months ended September 25, 2021 the Company recognized approximately $28 thousand and $148 thousand, respectively as share-based compensation expense related to share and option grants. These amounts are included as a component of selling, general and administrative expenses in the statement of operations.

XML

Note 6 - Inventories

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Inventory Disclosure [Text Block]

(6)   Inventories

Inventories consist of the following:

	October 1,			December 25,
	2022			2021
Raw materials	$	2,427,477		$	2,080,778
Work in process		2,032,969			1,309,572
Finished goods		574,417			805,159
Total inventory		5,034,863			4,195,509
Reserve for obsolescence		(166,313	)		(283,907	)
Inventories, net	$	4,868,550		$	3,911,602

XML

Note 7 - Accrued Expenses

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

(7)   Accrued Expenses

Accrued expenses consist of the following:

	October 1,		December 25,
	2022		2021
Accrued legal and accounting	$	38,148	$	79,917
Accrued payroll		693,382		905,698
Accrued other		134,007		100,814
	$	865,537	$	1,086,429

XML

Note 8 - Line of Credit

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Debt Disclosure [Text Block]

(8)   Line of Credit

In September 2019, the Company entered into a revolving line of credit (LOC) with Massachusetts Business Development Corporation (BDC) in the amount of $2.5 million. The agreement includes a demand note allowing the Lender to call the loan at any time. The Company may terminate the agreement without a termination fee after 3 years. In May of 2020 this credit line was increased to $3.0 million. The LOC is secured by the accounts receivable and other assets of the Company and had an interest rate of LIBOR plus 650 basis points. In May of 2021 the interest rate was reduced to LIBOR plus 550 basis points. On October 1, 2022, the Company had $0 of borrowings under this LOC and its borrowing base at the time would have permitted an additional $3.0 million to have been borrowed.

The line of credit is subject to certain financial covenants, all of which have been met or waived.

XML

Note 9 - Note Payable

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Long-Term Debt [Text Block]

(9)   Note Payable         

In March 2020, the company acquired inspection equipment for a price of $208 thousand. The full amount was financed through a 5 year note payable with a third party equipment finance company. The note is collateralized by the equipment and is being paid in monthly installments of $4 thousand, consisting of principal plus interest at a rate of 6.47%.

In July 2020 CPS placed into service a piece of manufacturing equipment which it financed with the machine’s vendor. The equipment cost of $40 thousand was paid in full during the quarter ended October 1, 2022.

The aggregate maturities of the notes payable based on the payment terms of the agreement are as follows: 

Remaining in:	Payments due by period
FY 2022	$	10,399
FY 2023	$	43,837
FY 2024	$	46,757
FY 2025	$	8,090
Total		109,083

Total interest expense on notes payable during 2022 was $6,243.

XML

Note 10 - Income Taxes

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Income Tax Disclosure [Text Block]

(10)   Income Taxes

A valuation allowance against deferred tax assets is required to be established or maintained when it is "more likely than not" that all or a portion of deferred tax assets will not be realized. In December 2018, the Company established a valuation allowance reserve, as it is judged more likely than not that all or a portion of its deferred tax assets will not be utilized before they expire. This decision was reached after giving greater weight to the Company’s losses in recent years as compared to its forecasts.

In September 2021, this decision was reevaluated in light of the Company’s recent profitability and its forecasts for future profitability. The Company concluded that it is “more likely than not” that the Company will be able to fully utilize the deferred tax asset. This reversal of the valuation allowance was made net of the expected tax liability for 2021 in the amount of $2,790,201. For the third quarter of 2022 a charge against the tax asset of $364,497 for the estimated tax liability on Q3 income was made. For the 9 months ended October 1, 2022, a charge against the tax asset of $705,755 was made for the estimated tax liability on year-to-date income.  The Company has calculated its tax liability using a 21% rate for federal taxes and an 8.6% rate for state taxes.

XML

Note 11 - Other Taxes

9 Months Ended

Oct. 01, 2022

Notes to Financial Statements

Other Taxes [Text Block]

(11)   Other Taxes

In Q3 the Company determined that it was eligible for the Employee Retention Tax Credit (“ERTC”). This amount was determined to be $641,086 and is included in Accounts Receivable and Other Income. The Company has filed its tax returns to reflect this income and has included its impact in the Q3 tax calculation.

XML

Note 3 - Net Income (Loss) Per Common and Common Equivalent Share (Tables)

9 Months Ended

Oct. 01, 2022

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended				Nine Months Ended
	October 1,		September 25,		October 1,		September 25,
	2022		2021		2022		2021
Basic EPS Computation:
Numerator:
Net income	$	987,865	$	2,727,967	$	1,862,409	$	2,998,067
Denominator:
Weighted average Common shares Outstanding		14,434,468		14,324,136		14,417,995		13,963,563
Basic EPS	$	0.07	$	0.19	$	0.13	$	0.21
Diluted EPS Computation:
Numerator:
Net income	$	987,865	$	2,727,967	$	1,862,409	$	2,998,067
Denominator:
Weighted average Common shares Outstanding		14,434,468		14,324,136		14,417,995		13,963,563
Dilutive effect of stock options		252,008		487,124		265,637		578,793
Total Shares		14,686,476		14,811,259		14,683,632		14,542,356
Diluted EPS	$	0.07	$	0.18	$	0.13	$	0.21

XML

Note 4 - Commitments & Contingencies (Tables)

9 Months Ended

Oct. 01, 2022

Notes Tables

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

(Dollars in Thousands)	October 1, 2022
Maturity of capitalized lease liabilities	Lease payments
2022		41
2023		162
2024		165
2025		165
2026		28
Total undiscounted operating lease payments	$	561
Less: Imputed interest		(64	)
Present value of operating lease liability	$	497
Balance Sheet Classification
Current lease liability	$	157
Long-term lease liability		340
Total operating lease liability	$	497
Other Information
Weighted-average remaining lease term for capitalized operating leases (in months)		41
Weighted-average discount rate for capitalized operating leases		6.6	%

XML

Note 6 - Inventories (Tables)

9 Months Ended

Oct. 01, 2022

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	October 1,			December 25,
	2022			2021
Raw materials	$	2,427,477		$	2,080,778
Work in process		2,032,969			1,309,572
Finished goods		574,417			805,159
Total inventory		5,034,863			4,195,509
Reserve for obsolescence		(166,313	)		(283,907	)
Inventories, net	$	4,868,550		$	3,911,602

XML

Note 7 - Accrued Expenses (Tables)

9 Months Ended

Oct. 01, 2022

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

	October 1,		December 25,
	2022		2021
Accrued legal and accounting	$	38,148	$	79,917
Accrued payroll		693,382		905,698
Accrued other		134,007		100,814
	$	865,537	$	1,086,429

XML

Note 9 - Note Payable (Tables)

9 Months Ended

Oct. 01, 2022

Notes Tables

Schedule of Maturities of Long-Term Debt [Table Text Block]

Remaining in:	Payments due by period
FY 2022	$	10,399
FY 2023	$	43,837
FY 2024	$	46,757
FY 2025	$	8,090
Total		109,083

XML

Note 3 - Net Income (Loss) Per Common and Common Equivalent Share - Table of Both Basic and Diluted EPS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Sep. 25, 2021	Oct. 01, 2022	Sep. 25, 2021
Basic EPS Computation:
Net income	$ 987,865	$ 2,727,967	$ 1,862,409	$ 2,998,067
Weighted average Common shares Outstanding (in shares)	14,434,468	14,324,136	14,417,995	13,963,563
Basic EPS (in dollars per share)	$ 0.07	$ 0.19	$ 0.13	$ 0.21
Diluted EPS Computation:
Net income	$ 987,865	$ 2,727,967	$ 1,862,409	$ 2,998,067
Weighted average Common shares Outstanding (in shares)	14,434,468	14,324,136	14,417,995	13,963,563
Dilutive effect of stock options (in shares)	252,008	487,124	265,637	578,793
Total Shares (in shares)	14,686,476	14,811,259	14,683,632	14,542,356
Diluted EPS (in dollars per share)	$ 0.07	$ 0.18	$ 0.13	$ 0.21

XML

Note 4 - Commitments & Contingencies (Details Textual) ft² in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 01, 2022 USD ($) ft²	Oct. 01, 2022 USD ($) ft²
Area of Real Estate Property (Square Foot) | ft²	38	38
Norton Facility [Member]
Operating Lease, Expense	$ 41	$ 120
Minimum [Member]
Lessee, Operating Lease, Annual Rent Payments		152
Maximum [Member]
Lessee, Operating Lease, Annual Rent Payments		$ 165

XML

Note 4 - Commitments & Contingencies - Maturity of Capitalized Lease Liabilities (Details) - USD ($)	Oct. 01, 2022	Dec. 25, 2021
2022	$ 41,000
2023	162,000
2024	165,000
2025	165,000
2026	28,000
Total undiscounted operating lease payments	561,000
Less: Imputed interest	(64,000)
Present value of operating lease liability	497,000
Current lease liability	157,000	$ 155,000
Long-term lease liability	340,000	$ 431,000
Total operating lease liability	$ 497,000
Weighted-average remaining lease term for capitalized operating leases (in months) (Year)	41 years
Weighted-average discount rate for capitalized operating leases	6.60%

XML

Note 5 - Share-based Payments (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 01, 2022	Sep. 25, 2021	Oct. 01, 2022	Sep. 25, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)	0	500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)	10,000	32,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period (in shares)	0	0
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in dollars per share)		$ 1.49
Stock Repurchased During Period, Shares (in shares)	0	112
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)	983,100		983,100
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance (in dollars per share)	$ 2.44		$ 2.44
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Year)	6 years 3 months 18 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number (in shares)	518,800		518,800
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 2.03		$ 2.03
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Year)	4 years 3 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)	1,500,000		1,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)	915,800		915,800
Share-Based Payment Arrangement, Expensed and Capitalized, Amount, Total	$ 43	$ 28	$ 207	$ 148
Equity Incentive Plan Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	25,000	5,000

XML

Note 6 - Inventories - Inventories (Details) - USD ($)	Oct. 01, 2022	Dec. 25, 2021
Raw materials	$ 2,427,477	$ 2,080,778
Work in process	2,032,969	1,309,572
Finished goods	574,417	805,159
Total inventory	5,034,863	4,195,509
Reserve for obsolescence	(166,313)	(283,907)
Inventories, net	$ 4,868,550	$ 3,911,602

XML

Note 7 - Accrued Expenses - Accrued Expenses (Details) - USD ($)	Oct. 01, 2022	Dec. 25, 2021
Accrued legal and accounting	$ 38,148	$ 79,917
Accrued payroll	693,382	905,698
Accrued other	134,007	100,814
Accounts Payable and Accrued Liabilities, Current, Total	$ 865,537	$ 1,086,429

XML

Note 8 - Line of Credit (Details Textual) - Massachusetts Business Development Corporation [Member] - Revolving Credit Facility [Member] - USD ($) $ in Thousands		1 Months Ended
	Sep. 30, 2019	May 31, 2021	May 31, 2020	Oct. 01, 2022
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,500		$ 3,000
Debt Instrument, Termination Period (Year)	3 years
Long-term Line of Credit, Total				$ 0
Line of Credit Facility, Remaining Borrowing Capacity				$ 3,000
London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate		5.50%	6.50%

XML

Note 9 - Note Payable (Details Textual) - USD ($)	1 Months Ended	9 Months Ended
	Mar. 31, 2020	Oct. 01, 2022	Dec. 25, 2021
Property, Plant and Equipment, Gross, Ending Balance		$ 12,680,114	$ 12,114,418
Interest Expense, Debt, Total		6,243
Microscope Note Payable [Member]
Debt Instrument, Term (Year)	5 years
Debt Instrument, Periodic Payment, Total	$ 4,000
Debt Instrument, Interest Rate, Stated Percentage	6.47%
Machine Vendor Financing [Member]
Debt Instrument, Repurchased Face Amount		$ 40,000
Sonoscan Ultrasound Microscope [Member]
Property, Plant and Equipment, Gross, Ending Balance	$ 208,000

XML

Note 9 - Note Payable - Note Payable Maturities (Details)	Oct. 01, 2022 USD ($)
FY 2022	$ 10,399
FY 2023	43,837
FY 2024	46,757
FY 2025	8,090
Total	$ 109,083

XML

Note 10 - Income Taxes (Details Textual) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Oct. 01, 2022	Oct. 01, 2022	Dec. 25, 2021
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 364,497	$ 705,755	$ 2,790,201
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent		21.00%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent		8.60%

XML

Note 11 - Other Taxes (Details Textual)	Oct. 01, 2022 USD ($)
Accounts Receivable and Other Income [Member]
Employee Retention Tax Credit	$ 641,086